大博医疗收盘上涨10.00%，滚动市盈率51.10倍，总市值203.49亿元

Group 1 - The core viewpoint of the article highlights that Dabo Medical's stock price increased by 10.00% to 49.15 yuan, with a rolling PE ratio of 51.10, marking a new low in 846 days, and a total market capitalization of 20.349 billion yuan [1] - Dabo Medical ranks 86th in the medical device industry based on a sector average PE of 54.31 and a median PE of 38.11 [1] - As of March 31, 2025, Dabo Medical has 18,310 shareholders, an increase of 374 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Group 2 - Dabo Medical specializes in the production, research, and sales of high-value medical consumables, with key products including intramedullary nails, external fixators, and various orthopedic implants [1] - The latest quarterly report for Q1 2025 shows Dabo Medical achieved a revenue of 550 million yuan, a year-on-year increase of 28.80%, and a net profit of 103 million yuan, up 67.04%, with a gross profit margin of 69.64% [1] - The PE ratio of Dabo Medical is compared to other companies in the industry, with the average PE at 54.31 and the median at 38.11, indicating a relatively high valuation for Dabo Medical [2]